Global Information
회사소개 | 문의 | 비교리스트

세계의 심방세동(AF) 시장 : 지역별, 국가별 분석

Global Atrial Fibrillation Market (Non-Surgical/Catheter, Surgical-Mini Maze, Hybrid): Analysis By Region, By Country 2016-2021

리서치사 Azoth Analytics
발행일 2016년 10월 상품 코드 376373
페이지 정보 영문 124 Pages
가격
US $ 2,400 ₩ 2,982,000 PDF by E-mail (Single User License)
US $ 4,000 ₩ 4,971,000 PDF by E-mail (Multi User License)


세계의 심방세동(AF) 시장 : 지역별, 국가별 분석 Global Atrial Fibrillation Market (Non-Surgical/Catheter, Surgical-Mini Maze, Hybrid): Analysis By Region, By Country 2016-2021
발행일 : 2016년 10월 페이지 정보 : 영문 124 Pages

세계의 심방세동(AF) 시장은 2016-2021년간 CAGR(연평균 성장률)로 13.26%의 성장이 예측됩니다.

세계의 심방세동(AF) 시장에 대해 조사분석했으며, 부문별 실적과 향후 안내, 국가별 분석, 시장 역학, 정책·규제 상황, 경쟁 구도 등의 정보를 정리하여 전해드립니다.

제1장 조사 방법

제2장 개요

제3장 전략적 제안

제4장 제품 개요

제5장 세계의 심방세동(AF) 시장 개요

  • 세계의 심방세동(AF) 시장 : 금액별(실적)
  • 세계의 심방세동(AF) 시장 : 금액별(예측)
  • 세계의 AF 절제 시장 : 시술 종류별
  • 세계의 심방세동(AF) 시장 : 지역별
  • 세계의 비외과적/카테터 AF 절제 시장 : 금액별
  • 세계의 외과적 AF 절제 시장 : 금액별
  • 세계의 외과적 AF 시장 : 시술 종류별
  • 세계의 미니 메이즈 AF 절제 시장 : 금액별
  • 세계의 하이브리드 AF 절제 시장 : 금액별

제6장 북미의 심방세동(AF) 시장 개요

  • 북미
  • 미국
  • 캐나다

제7장 유럽의 심방세동(AF) 시장 개요

  • 유럽
  • 독일
  • 영국

제8장 아시아태평양 지역의 심방세동(AF) 시장 개요

  • 아시아태평양 지역
  • 일본
  • 중국

제9장 기타 지역의 심방세동(AF) 시장 개요

  • 기타 지역

제10장 시장 동향

제11장 시장 역학

  • 촉진요인
  • 과제

제12장 정책·규제 상황

제13장 상환 정책

제14장 기업 개요

  • St. Jude Medical
  • Medtronic
  • Boston Scientific Corporation
  • Atricure Inc.
  • Cardiofocus Inc.
  • Biosense Webster Inc.
  • Biotronik
  • TZ Medical
KSA 16.11.17

Executive Summary

A comprehensive research report titled “Global Atrial Fibrillation (Afib) Market (Non-Surgical/Catheter, Surgical- Mini Maze, Hybrid): Analysis By Region, By Country (2016-2021F)” created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, presents the analysis of the global atrial fibrillation or Afib market and has been segmented By Procedures (Surgical Ablation- Mini Maze, Hybrid, Non-Surgical - Catheter); By Region (North America, Europe, APAC, ROW) and By Country (U.S., Canada, UK, Germany, China, Japan).

Market for Afib is growing steadily on account of the rising number of Afib cases, which is caused by the lifestyle related diseases, such as hypertension, diabetes, obesity, and is gaining prominence among both adult and aged population. Rising cases of atrial fibrillation (Afib) among the population along with the growing focus on catheter ablation procedures has led to the growth of atrial fibrillation market.

Among the segments, market is expected to be driven by catheter ablation procedures on account of the technological improvement leading to higher success rates among the patients.

While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure, leading to increase in ablation centres and rising focus on healthcare among the growing middle class population.

Global Atrial Fibrillation Market is forecasted to grow at a CAGR of 13.26% during 2016 - 2021F, on account of rising Afib among the population. North America region remains the major market among all the regions. In the forecast period, APAC region will witness strong growth driven by the countries such as Japan and China.

According to Azoth Analytics research report, Global Atrial Fibrillation (Afib) Market (Non-Surgical/Catheter, Surgical- Mini Maze, Hybrid): Analysis By Region, By Country (2016-2021F), Global Atrial Fibrillation market is projected to exhibit a CAGR of over ~13.26% during 2016 - 2021.

Scope of the Report

The report provides Segmentation by Procedures

  • Surgical Ablation - Mini Maze, Hybrid
  • Non-Surgical - Catheter

The report provides coverage by Region

  • North America
  • Europe
  • Asia Pacific
  • ROW

The report provides coverage by Country

  • USA
  • Canada
  • UK
  • Germany
  • Japan
  • China

Customization of the Report

The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Product Overview

5. Global Atrial Fibrillation Market Overview

  • 5.1. Global Atrial Fibrillation Market, By Value ,Historic 2011-2015
  • 5.2. Global Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
  • 5.3. Global AF Ablation Market, By Procedure Types
    • 5.3.1. Historic
    • 5.3.2. Forecast
  • 5.4. Global Atrial Fibrillation Market , By Region
    • 5.4.1. Historic -2015(%)
    • 5.4.2. Forecast -2021(%)
  • 5.5. Global Non Surgical/Catheter AF Ablation Market, By Value, Historic 2011-2015
  • 5.6. Global Non Surgical/Catheter AF Ablation Market, By Value, Forecast 2016E-2021F
  • 5.7. Global Surgical AF Ablation Market, By Value, Historic 2011-2015
  • 5.8. Global Surgical AF Ablation Market, By Value, Forecast 2016E-2021F
  • 5.9. Global Surgical Atrial Fibrillation Market, By Procedure Types
    • 5.9.1. Historic -2015(%)
    • 5.9.2. Forecast -2021(%)
  • 5.10. Global Mini Maze AF Ablation Market, By Value, Historic 2011-2015
  • 5.11. Global Mini Maze AF Ablation Market, By Value, Forecast 2016E-2021F
  • 5.12. Global Hybrid AF Ablation Market, By Value, Historic 2011-2015
  • 5.13. Global Hybrid AF Ablation Market, By Value, Forecast 2016E-2021F

6. North America Atrial Fibrillation Market Overview

  • 6.1. North America Atrial Fibrillation Market, By Value, Historic 2011-2015
  • 6.2. North America Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
  • 6.3. North America Atrial Fibrillation Market, By Country
    • 6.3.1. Historic -2015(%)
    • 6.3.2. Forecast -2021(%)
  • 6.4. United States Atrial Fibrillation Market, By Value, Historic 2011-2015
  • 6.5. Unites States Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
  • 6.6. Canada Atrial Fibrillation Market, By Value, Historic 2011-2015
  • 6.7. Canada Atrial Fibrillation Market, By Value, Forecast 2016E-2021F

7. Europe Atrial Fibrillation Market Overview

  • 7.1. Europe Atrial Fibrillation Market, By Value, Historic 2011-2015
  • 7.2. Europe Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
  • 7.3. Europe Atrial Fibrillation Market, By Country
    • 7.3.1.Historic -2015(%)
    • 7.3.2.Forecast -2021(%)
  • 7.4. Germany Atrial Fibrillation Market, By Value, Historic 2011-2015
  • 7.5. Germany Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
  • 7.6. United Kingdom Atrial Fibrillation Market, By Value, Historic 2011-2015
  • 7.7. United Kingdom Atrial Fibrillation Market, By Value, Forecast 2016E-2021F

8. Asia Pacific Atrial Fibrillation Market Overview

  • 8.1. Asia Pacific Atrial Fibrillation Market, By Value, Historic 2011-2015
  • 8.2. Asia Pacific Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
  • 8.3. Asia Pacific Atrial Fibrillation Market, By Country
    • 8.3.1. Historic -2015(%)
    • 8.3.2. Forecast -2021(%)
  • 8.4. Japan Atrial Fibrillation Market, By Value, Historic 2011-2015
  • 8.5. Japan Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
  • 8.6. China Atrial Fibrillation Market, By Value, Historic 2011-2015
  • 8.7. China Atrial Fibrillation Market, By Value, Forecast 2016E-2021F

9. ROW Atrial Fibrillation Market Overview

  • 9.1. ROW Atrial Fibrillation Market, By Value, Historic 2011-2015
  • 9.2. ROW Atrial Fibrillation Market, By Value, Forecast 2016E-2021F

10. Market Trends

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Policy and Regulatory Landscape

13. Reimbursement Policies

14. Company Profiling

  • 14.1. St. Jude Medical
  • 14.2. Medtronic
  • 14.3. Boston Scientific Corporation
  • 14.4. Atricure Inc.
  • 14.5. Cardiofocus Inc.
  • 14.6. Biosense Webster Inc.
  • 14.7. Biotronik
  • 14.8. TZ Medical

List of Figure

  • Figure 1: Global AF Ablation Market, By Value, Historic (2011-2015) in USD Billion
  • Figure 2: Global AF Ablation Market, By Value, Forecast (2016E-2021F) in USD Billion
  • Figure 3: Afib Patients in Western Europe in million
  • Figure 4: Afib Patients in United States in million
  • Figure 5: Global Afib Patients in million
  • Figure 6: The Benefit payable for MBS item number 38290 during 2011-12 & 2012-13
  • Figure 7: Global AF Ablation Market , By procedures -2015(%)
  • Figure 8: Global AF Ablation Market , By procedures -2021F(%)
  • Figure 9: Global AF Ablation Market , By Region -2015(%)
  • Figure 10: Global AF Ablation Market , By Region -2021F(%)
  • Figure 11: Global Non Surgical AF Ablation Market , By Value , Historic(2011-2015) in USD Billion
  • Figure 12: Global Non Surgical AF Ablation Market , By Value , Forecast(2016E-2021F) in USD Billion
  • Figure 13: United States Prevalence of Afib Symptoms in Adults (in millions) 2010-2025
  • Figure 14: Europe Percentage of adults with atrial fibrillation 2010-2025
  • Figure 15: Global Surgical AF Ablation Market, By Value, Historic (2011-2015) in USD Billion
  • Figure 16: Global Surgical AF Ablation Market, By Value, Forecast (2016E-2021F) in USD Billion
  • Figure 17: Persistent Afib Patients in Germany (in million)
  • Figure 18: Japan-Percentage Rise in Prevalence of Permanent Afib
  • Figure 19: Global Surgical AF Ablation Market, By procedures -2015(%)
  • Figure 20: Global Surgical AF Ablation Market, By procedures -2021F (%)
  • Figure 21: Global Mini Maze AF Ablation Market, By Value, Historic (2011-2015) in USD Billion
  • Figure 22: Global Mini Maze Ablation Market, By Value, Forecast (2016E-2021F) in USD Billion
  • Figure 23: Frequency of different types of atrial fibrillation
  • Figure 24: Global Hybrid AF Ablation Market, By Value, Historic (2011-2015) in USD Billion
  • Figure 25: Global Hybrid Ablation Market, By Value, Forecast (2016E-2021F) in USD Billion
  • Figure 26: North America AF Ablation Market, By Value, Historic (2011-2015) in USD Billion
  • Figure 27: North America AF Ablation Market, By Value, Forecast (2016E-2021F) in USD Billion
  • Figure 28: North America AF Ablation Market, By Country -2015(%)
  • Figure 29: North America AF Ablation Market, By Country -2021F (%)
  • Figure 30: United States AF Ablation Market, By Value, Historic (2011-2015) in USD Billion
  • Figure 31: United States AF Ablation Market, By Value, Forecast (2016E-2021F) in USD Billion
  • Figure 32: United Sates - Prevalence of Afib Patients (in million)
  • Figure 33: Canada AF Ablation Market, By Value, Historic (2011-2015) in USD Billion
  • Figure 34: Canada AF Ablation Market, By Value, Forecast (2016E-2021F) in USD Billion
  • Figure 35: Canada -Prevalence of Afib Patients (in million)
  • Figure 36: Canada- Minimally Invasive Procedures Performed
  • Figure 37: Europe AF Ablation Market, By Value, Historic (2011-2015) in USD Billion
  • Figure 38: Europe AF Ablation Market, By Value, Forecast (2016E-2021F) in USD Billion
  • Figure 39: Europe AF Ablation Market, By Country -2015(%)
  • Figure 40: Europe AF Ablation Market, By Country -2021F (%)
  • Figure 41: Germany AF Ablation Market, By Value, Historic (2011-2015) in USD Billion
  • Figure 42: Germany AF Ablation Market, By Value, Forecast (2016E-2021F) in USD Billion
  • Figure 43: Germany Ablation Procedures
  • Figure 44: Germany Ablation Centres
  • Figure 45: United Kingdom AF Ablation Market, By Value, Historic (2011-2015) in USD Billion
  • Figure 46: United Kingdom AF Ablation Market, By Value, Forecast (2016E-2021F) in USD Billion
  • Figure 47: England Prevalence of Atrial Fibrillation
  • Figure 48: Asia Pacific AF Ablation Market, By Value, Historic (2011-2015) in USD Billion
  • Figure 49: Asia Pacific AF Ablation Market, By Value, Forecast (2016E-2021F) in USD Billion
  • Figure 50: Asia Pacific AF Ablation Market, By Country -2015(%)
  • Figure 51: Asia Pacific AF Ablation Market, By Country -2021F (%)
  • Figure 52: Japan AF Ablation Market, By Value, Historic (2011-2015) in USD Billion
  • Figure 53: Japan AF Ablation Market, By Value, Forecast (2016E-2021F) in USD Billion
  • Figure 54: Japan AF Ablation Centres
  • Figure 55: Japan AF Ablation Procedures
  • Figure 56: Japan AF Ablation Physicians
  • Figure 57: China AF Ablation Market , By Value , Historic(2011-2015) in USD Billion
  • Figure 58: China AF Ablation Market , By Value , Historic(2016E-2021F) in USD Billion
  • Figure 59: China AF Ablation Centres
  • Figure 60: China AF Ablation Procedures
  • Figure 61: China Hospitalization Rate Due to Atrial Fibrillation
  • Figure 62: China - Percentage of Chinese Patients suffering from Atrial Fibrillation
  • Figure 63: ROW AF Ablation Market , By Value , Historic(2011-2015) in USD Billion
  • Figure 64: ROW AF Ablation Market , By Value , Historic(2016E-2021F) in USD Billion
  • Figure 65: Egypt- Percentage of patients suffered from stroke due to atrial fibrillation
  • Figure 66: UAE - Rising Prevalence of Atrial Fibrillation
  • Figure 67: Latin America - Prevalence of Atrial Fibrillation - 2015
  • Figure 68: Percentage rise in the Afib Patients
  • Figure 69: United States Rise in number of Afib Patients in millions
  • Figure 70: St. Jude Medical Inc. (USD Billion) 2011-2015
  • Figure 71: Net Sales By Geography -2014
  • Figure 72: Net Sales By Geography -2015
  • Figure 73: Net Sales By Product Category -2014
  • Figure 74: Net Sales By Product Category -2015
  • Figure 75: Medtronic PLC(USD Billion ) 2011-2015
  • Figure 76: Boston Scientific Corporation (USD Billion) 2011-2015
  • Figure 77: Net Sales By Product Category -2014
  • Figure 78: Net Sales By Product Category -2015
  • Figure 79: Atricure Inc.(USD Million) 2011-2015

List of Tables

  • Table 1: Medicare Reimbursement for Endovascular and Open Ablation
  • Table 2: Medicare Reimbursement Rate for CY-2015& CY-2016
  • Table 3: 2015-2016 National Average Medicare Reimbursement
Back to Top
전화 문의
F A Q